| Structure |
Chemical Name |
CAS |
MF |
![Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-](/CAS/20210305/GIF/2469039-94-7.gif) |
Benzamide, 3-[[5-chloro-4-(3-pyridinyl)-2-pyrimidinyl]amino]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]- |
2469039-94-7 |
C28H21ClF3N7O |
![N,N,N-トリメチル-4-[(4,7,7-トリメチル-3-オキソビシクロ[2.2.1]ヘプタ-2-イリデン)メチル]ベンゼンアミニウム・メチルスルファート](/CAS/GIF/52793-97-2.gif) |
N,N,N-トリメチル-4-[(4,7,7-トリメチル-3-オキソビシクロ[2.2.1]ヘプタ-2-イリデン)メチル]ベンゼンアミニウム・メチルスルファート |
52793-97-2 |
C21H31NO5S |
 |
4-ヒドロキシ-2-オキソ-1-ピロリジン酢酸エチル |
62613-81-4 |
C8H13NO4 |
 |
(±)-バシシン |
6159-56-4 |
C11H12N2O |
 |
Nicergoline Impurity 12 |
|
|
|
|
Rosuvastatin Impurity 156 |
|
|
![Acetamide, N-(2-aminoethyl)-2-[(3-hydroxyphenyl)(4-methylphenyl)amino]-](/CAS/20210305/GIF/2724727-52-8.gif) |
Acetamide, N-(2-aminoethyl)-2-[(3-hydroxyphenyl)(4-methylphenyl)amino]- |
2724727-52-8 |
C17H21N3O2 |
![(3R,4R)-3-ヒドロキシ-N-メチル-5-[(E)-1-プロペニル]-シクロ(L-Leu-L-Nva-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-)](/CAS/GIF/74436-00-3.gif) |
(3R,4R)-3-ヒドロキシ-N-メチル-5-[(E)-1-プロペニル]-シクロ(L-Leu-L-Nva-Sar-N-メチル-L-Leu-L-Val-N-メチル-L-Leu-L-Ala-D-Ala-N-メチル-L-Leu-N-メチル-L-Leu-N-メチル-L-Val-) |
74436-00-3 |
C63H113N11O12 |
 |
1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)- |
2640280-85-7 |
C22H24N4O3 |
 |
L-Ampicillin |
19379-33-0 |
C16H19N3O4S |
 |
アルジシアクリスピンB |
112766-96-8 |
C53H86O22 |
 |
3-(オキサロアミノ)-L-アラニン |
5302-45-4 |
C5H8N2O5 |
 |
2-(2,4-ジヒドロキシベンゾイル)安息香酸 |
2513-33-9 |
C14H10O5 |
 |
N-ベンジルヘプタンアミド |
55917-07-2 |
C14H21NO |
 |
アムロジピンジエチルエステル |
140171-65-9 |
C21H27ClN2O5 |
 |
Dehydro Simvastatin |
210980-68-0 |
C25H36O4 |
 |
Mono-POC Isopropyl Tenofovir |
1422284-15-8 |
C21H32N5O11P |
 |
セファレキシンジケトピペラジン一酸(MIXTURE OF DIASTEREOMERS) |
1323247-65-9 |
C16H19N3O5S |
 |
2-Des(acetylthioMethyl)-2-Methylene Racecadotril |
87428-99-7 |
C19H19NO3 |
![1-(5-クロロベンゾオキサゾール-2-イル)-4-[5-メチル-2-(2H-1,2,3-トリアゾール-2-イル)ベンゾイル]-5β-メチル-1,4-ジアザシクロヘプタン](/CAS/GIF/1030377-80-0.gif) |
1-(5-クロロベンゾオキサゾール-2-イル)-4-[5-メチル-2-(2H-1,2,3-トリアゾール-2-イル)ベンゾイル]-5β-メチル-1,4-ジアザシクロヘプタン |
1030377-80-0 |
C23H23ClN6O2 |
 |
イカリシド I |
56725-99-6 |
C27H30O11 |
 |
ビスサルブタモールエーテル |
147663-30-7 |
C26H40N2O5 |
|
|
edaravone iMpurity A |
|
|
 |
Pantoprazole EP IMpurity E |
2115779-15-0 |
C32H28F4N6O8S2 |
 |
BUTYL ANALOG OF TAXOL, n-(RG) |
173101-55-8 |
C45H55NO14 |
![Toluene-4-sulfonic acid 5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylMethyl-tetrahydro-furan-3-ylMethyl](/CAS/20180808/GIF/159811-30-0.gif) |
Toluene-4-sulfonic acid 5-(2,4-difluoro-phenyl)-5-[1,2,4]triazol-1-ylMethyl-tetrahydro-furan-3-ylMethyl |
159811-30-0 |
C21H21F2N3O4S |
 |
Azilsartan iMpurity A |
147404-76-0 |
C25H23N3O4 |
 |
Apixaban IMpurity 2 |
1801881-16-2 |
C25H25N5O4 |
 |
Lidocaine IMpurity E |
745798-07-6 |
C20H25N3O2 |
 |
Dabigatran iMpurity J |
211915-00-3 |
C33H39N7O5 |
 |
N-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonaMide |
1195768-20-7 |
C18H11ClF3N3O3S |
 |
DL-β-O-Methylnorepinephrine Hydrochloride |
3770-01-2 |
C9H14ClNO3 |
 |
LincoMycin 2-Phosphate |
27480-30-4 |
C18H35N2O9PS |
 |
((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)Methyl acetate |
864070-37-1 |
C19H21ClO6 |
 |
Isavuconazole Impurity |
21661-87-0 |
C9H5Br2NO |
 |
Ceftaroline Fosamil Impurity 8 |
1286218-63-0 |
C22H23N8O9PS4 |
 |
Buspirone EP Impurity C |
257877-45-5 |
C20H30N8 |
 |
Imipenem Impurity |
776257-75-1 |
C24H34N6O8S2 |
 |
(3R,8S,9S,12S) Atazanavir |
1332981-14-2 |
C38H52N6O7 |
 |
Anisamide, 3-ethoxy- |
247569-89-7 |
C10H13NO3 |
 |
Cefotiam Impurity 1 |
775233-43-7 |
C13H14N4O5S2 |
 |
Sitagliptin EP Impurity C |
945261-48-3 |
C16H16F5N5O |
 |
3-Thiomorpholinecarboxylic acid, 5-oxo-, 1-oxide |
88620-38-6 |
C5H7NO4S |
 |
アンヒドロサフロールイエローB |
184840-84-4 |
C48H52O26 |
 |
(4S)-2-(((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4 |
42947-63-7 |
C16H21N3O6S |
 |
2-(tert-butylamino)-1-(4-hydroxy-3-methylphenyl)ethan-1-one |
60853-66-9 |
C13H19NO2 |
 |
AmBroxol Impurity 11 |
2088879-81-4 |
C14H16Br2N2O |
 |
Famotidine EP Impurity H |
106649-96-1 |
C6H10N6S2 |
 |
Fludarabine Phosphate EP Impurity C |
548774-53-4 |
C10H14FN5O10P2 |
|
|
Milrinone Impurity A |
|
|
 |
Parecoxib Impurity 4 |
57736-10-4 |
C14H13NO |
 |
Posaconazole Impurity 36 |
2243786-02-7 |
C30H35N5O3 |
 |
Lenalidomide Impurity 11 |
48103-74-8 |
C5H7NO3 |
 |
Paroxetine Related Impurity 9 |
253768-88-6 |
C26H24FNO5 |
![(2S,5R)-N-(3-aminopropyloxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide trifluoroacetic acid salt](/CAS/20211123/GIF/1572989-40-2.gif) |
(2S,5R)-N-(3-aminopropyloxy)-7-oxo-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide trifluoroacetic acid salt |
1572989-40-2 |
C12H19F3N4O9S |
|
|
Ritonavir EP Impurity ABC |
|
|
![(3R)-3β,4β-ジヒドロキシ-5α-[3-(3,4-ジヒドロキシフェニル)アクリロイルオキシ]-1-シクロヘキセン-1-カルボン酸](/CAS/GIF/73263-62-4.gif) |
(3R)-3β,4β-ジヒドロキシ-5α-[3-(3,4-ジヒドロキシフェニル)アクリロイルオキシ]-1-シクロヘキセン-1-カルボン酸 |
73263-62-4 |
C16H16O8 |
![Benzenecarboximidic acid, 4-[3-(aminocarbonyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridin-4-yl]-3-methoxy-, ethyl ester](/CAS/20210305/GIF/2640280-83-5.gif) |
Benzenecarboximidic acid, 4-[3-(aminocarbonyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridin-4-yl]-3-methoxy-, ethyl ester |
2640280-83-5 |
C23H28N4O4 |
 |
alpha-(3,4-dihydroxyphenyl)lactic acid |
22681-72-7 |
C9H10O5 |
 |
2-AMINO-3,5-DIBROMOBENZYL ALCOHOL |
50739-76-9 |
C7H7Br2NO |
 |
デクスプラミペキソール |
104632-28-2 |
C10H17N3S |
 |
Aprepitant-d4 |
1133387-60-6 |
C23H17D4F7N4O3 |
 |
5α-チルカラン-8,24-ジエン-3β-オール |
514-46-5 |
C30H50O |
 |
3-(ブロモメチル)-2-シクロプロピル-4-(4'-フルオロフェニル)キノリン |
154057-56-4 |
C19H15BrFN |
![1-[1-(Bromomethyl)ethenyl]-2,4-difluoro-benzene](/CAS2/GIF/159276-58-1.gif) |
1-[1-(Bromomethyl)ethenyl]-2,4-difluoro-benzene |
159276-58-1 |
C9H7BrF2 |
 |
3-Dechloro-3-broMo Trazodone Hydrochloride |
1263278-80-3 |
C19H23BrClN5O |
 |
N,N'-Desethylene-N,N'-diforMyl Levofloxacin |
151377-74-1 |
C18H18FN3O6 |
 |
トラボプロスト酸 |
54276-17-4 |
C23H29F3O6 |
 |
Atorvastatin IMpurity G |
887324-53-0 |
C34H37FN2O5 |
 |
Atorvastatin Impurity 20 |
1016893-70-1 |
C14H23NO4 |
 |
EsoMeprazole related substance H193/61 |
784143-42-6 |
C18H21N3O3S |
![(6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]aMino]-2-(4-hydroxyphenyl)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid](/CAS/GIF/1315481-36-7.gif) |
(6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]aMino]-2-(4-hydroxyphenyl)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid |
1315481-36-7 |
C25H27N9O8S2 |
 |
(E)-セフィキシム (セフィキシムEP不純物D) |
97164-56-2 |
C16H15N5O7S2 |
 |
1-(o-Chloro-α-phenylbenzyl)piperazine |
109036-15-9 |
C17H19ClN2 |
 |
2-アミノ-3-(4-ブロモベンゾイル)安息香酸 |
241496-82-2 |
C14H10BrNO3 |
![2-[(2-FuranylMethyl)sulfinyl]-N-[4-[[4-(1-piperidinylMethyl)-2-pyridinyl]oxy]butyl]acetaMide](/CAS/GIF/118288-14-5.gif) |
2-[(2-FuranylMethyl)sulfinyl]-N-[4-[[4-(1-piperidinylMethyl)-2-pyridinyl]oxy]butyl]acetaMide |
118288-14-5 |
C22H31N3O4S |
![2-[2-(2-Methyl-5-nitroiMidazol-1-yl)ethoxy]ethanol](/CAS/GIF/16156-94-8.gif) |
2-[2-(2-Methyl-5-nitroiMidazol-1-yl)ethoxy]ethanol |
16156-94-8 |
C8H13N3O4 |
![6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one](/CAS/GIF/851067-56-6.gif) |
6-broMo-8-cyclopentyl-5-Methyl-2-(5-(piperazin-1-yl)pyridin-2-ylaMino)pyrido[2,3-d]pyriMidin-7(8H)-one |
851067-56-6 |
C22H26BrN7O |
![4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](/CAS/20180906/GIF/1686149-74-5.gif) |
4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
1686149-74-5 |
C26H27N5O4 |
 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide |
198470-82-5 |
C20H20N2O4S |
 |
BroMocriptine IMpurity E |
2492-53-7 |
C16H16BrN3O |
 |
2-ペンチン-1-オール |
6261-22-9 |
C5H8O |
 |
(Z)-フルボキサミン |
89035-92-7 |
C15H21F3N2O2 |
![(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione](/CAS/20180703/GIF/CB93954895.gif) |
(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
1448443-35-3 |
C28H36N4O2S |
|
|
Pitavastatin Impurity 10 |
|
|
 |
Erlotinib Impurity 48 |
2304005-44-3 |
C8H8BrN |
 |
1,3-ジヒドロキシ-2-(ヒドロキシメチル)アントラキノン |
478-08-0 |
C15H10O5 |
 |
Posaconazole Succinyl Ester |
1488301-79-6 |
C41H46F2N8O7 |
 |
Rufinamide 2,6-Didesfluoro Impurity |
80819-65-4 |
C10H10N4O |
 |
Febuxostat Impurity 32 HCl |
1267681-15-1 |
C12H11NO3S |
|
|
Cilastatin Impurity C |
|
|
 |
Mometasone Furoate EP Impurity S |
2231764-75-1 |
C27H30Cl2O6 |
 |
Teriflunomide Impurity 2 |
220512-86-7 |
C12H9F3N2O2 |
 |
Dabigatran iMpurity K |
2225986-95-6 |
C34H41N7O5 |
|
|
Paroxetine Impurity 10（Paroxetine HCl Hemihydrate EP Impurity E） |
|
|
![Cefixime impurity 13/Cefixime TBE impurity A/Cefixime tert-Butyl Ester/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-(tert-butoxy)-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](/CAS/20210111/GIF/79368-92-6.gif) |
Cefixime impurity 13/Cefixime TBE impurity A/Cefixime tert-Butyl Ester/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-(tert-butoxy)-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
79368-92-6 |
C20H23N5O7S2 |
|
|
Cilastatin EP Impurity A |
|
|
 |
21-Hydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione |
56016-90-1 |
C22H28O3 |
|
|
Azlocillin Oxide Impurity |
|
|
 |
N-Desmethyl O-Methyl Clobazam |
2009208-96-0 |
C16H15ClN2O3 |